许吕宏，副主任医师，博士，毕业于中山大学，现为中山大学孙逸仙纪念医院儿学科硕士导师。是第17届中华医学会儿科分会青年委员，是Pediatr Hematol Oncol杂志和《中华儿科杂志》审稿专家，广东省科技业务管理评审专家。

从事儿童血液病基础与临床研究。

（1）Shi PJ#, Xu LH# , Lin KY, Weng WJ, Fang JP. Synergism between the mTOR inhibitor rapamycin and FAK down-regulation in the treatment of acute lymphoblastic leukemia. J Hematol Oncol 2016;9(1):12. (#Equal contribution authors). （IF=6.263） （2）Xu LH, Fang JP, Weng WJ, Huang K, Guo HX, Liu Y, Zhang JH. Pure red cell aplasia associated with cytomegalovirus and Epstein-Barr virus infection in 7 cases of Chinese children. Hematology 2013;18(1):56-59.（IF= 1.385） （3）Xu LH, Fang JP, Weng WJ, Huang K, Guo HX, Liu Y, Zhang JH. Pure red cell aplasia associated with cytomegalovirus and Epstein-Barr virus infection in 7 cases of Chinese children. Hematology 2013;18(1):56-59. （IF= 1.385） （4）Xu LH, Fang JP, Weng WJ, Huang K, Zhang YT. Autoimmune hemolytic anemia in patients with β-thalassemia major. Pediatr Hematol Oncol 2012;29(3):235- 240. （IF= 1.090） （5）Xu LH, Fang JP, Huang WG, Xu HG, Weng WJ, Kao GS, Le Y. Marrow graft rejection by repeated transfusions of allogeneic donor spleen cells. Bone Marrow Transplant 2007; 40(7): 691-698. （IF= 3.636）